Tikun Olam Cannbit Pharmaceuticals Ltd
TASE:TKUN
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| IL |
T
|
Tikun Olam Cannbit Pharmaceuticals Ltd
TASE:TKUN
|
19.7m ILS |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
986.4B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.1B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
286.3B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
235.3B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
239B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
301.2B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.3B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.4B USD |
Loading...
|
Market Distribution
| Min | -85 210% |
| 30th Percentile | -8.6% |
| Median | 1.8% |
| 70th Percentile | 7.2% |
| Max | 23 652.1% |
Other Profitability Ratios
Tikun Olam Cannbit Pharmaceuticals Ltd
Glance View
Tikun Olam-Cannbit Pharmaceuticals Ltd. engages in the cultivation and marketing of medical cannabis. The firm engages in growing and cultivating medical cannabis products.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Tikun Olam Cannbit Pharmaceuticals Ltd is -114.2%, which is above its 3-year median of -151.6%.
Over the last 3 years, Tikun Olam Cannbit Pharmaceuticals Ltd’s Net Margin has decreased from -65.4% to -114.2%. During this period, it reached a low of -210.5% on Jun 30, 2023 and a high of -65.4% on May 30, 2022.
